Two new large-scale and well-conducted clinical trials found that a short course of Lactobacillus rhamnosus GG or L. rhamnosus R0011 plus L. helveticus R0052 did not improve gastroenteritis symptoms in children.
From the 2018 midterm election results to the rise of CBD, Michael McGuffin, president of the American Herbal Products Association, talks about how the association is approaching the most recent changes in the supplements space.
The Nagoya Protocol, the big changes coming for Lactobacillus classification, and how to boost your chances of success with an NDI notification were just some of the topic covered during the third annual IPA Workshop in DC.
As the Supplement OWL approaches 12,000 labels in its Tier 1 product label library, the Council for Responsible has announced a new pilot program to build out Tier 2, which will be known as the Commercial Data Exchange, or CDX.
A paper that published this morning in the JAMA Network Open journal found that FDA had identified 776 adulterated dietary supplements in a 10-year period ending in 2016. As most of these products were tainted with drugs, calling them ‘supplements’ was...
Does DHSEA contain within it the seeds of the industry’s downfall? The freewheeling marketplace this regulation created has placed the barriers to entry so low that less than reputable companies have room to maneuver, creating risk for the whole industry.
Are supplements getting better? It’s a bit of a tricky question when applied to probiotics, as the ingredients are relatively new to the market. There are many examples of quality improvements within this category, but it exhibits some features that are...
Results from an omega-3 study found a positive link between treatment using EPA and cardiovascular outcomes. It was backed by pharmaceutical company Amarin, which enjoyed a 300% surge in shares after the study results were announced.
Supplement critic Dr Pieter Cohen has trained his sights on probiotics for a new opinion paper, stating that the sector has spun hundreds of small studies favorably and also practices creative advertising.
Like all emerging industries, sports nutrition thrives on innovation and a degree of risk-taking that has seen the likes of ketone-based drinks, probiotics and human milk oligosaccharides (HMOs) emerge as credible mainstream products.
A new BBC article dismisses the benefits of probiotics because a study failed to find colonization. It is a serious mistake to confuse colonization with efficacy and we need to get this message across to consumers.
A recent study reported something very impressive: A decade after the end of a randomized clinical trial, the benefits of dietary supplementation not only persisted, but seemed to be getting bigger. So why are we not talking about this more?
A recent mainstream press article that calls vitamin D research into question is a low blow that hinges on an attack on a prominent researcher’s character rather than a sober assessment of the science behind the nutrient, experts say.